Walleye Trading LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$258,912
-83.8%
12,748
-79.6%
0.00%
-100.0%
Q3 2022$1,600,000
+164.0%
62,400
+103.9%
0.01%
+150.0%
Q4 2021$606,000
-11.3%
30,600
-11.8%
0.00%0.0%
Q3 2021$683,000
+173.2%
34,700
+206.5%
0.00%
+100.0%
Q2 2021$250,000
+19.6%
11,323
+28.7%
0.00%0.0%
Q1 2021$209,000
-73.3%
8,800
-70.6%
0.00%
-75.0%
Q4 2020$782,000
+173.4%
29,900
+81.8%
0.00%
+100.0%
Q3 2020$286,000
-58.7%
16,447
-60.1%
0.00%
-60.0%
Q2 2020$693,000
+124.3%
41,200
+61.4%
0.01%
+150.0%
Q4 2019$309,000
+39.2%
25,524
+62.6%
0.00%
+100.0%
Q3 2019$222,000
-60.9%
15,693
-69.2%
0.00%
-80.0%
Q2 2019$568,000
+35.2%
50,900
+42.2%
0.01%
+66.7%
Q1 2019$420,000
+204.3%
35,800
+261.6%
0.00%
+200.0%
Q3 2018$138,000
-86.3%
9,900
-84.6%
0.00%
-80.0%
Q2 2018$1,008,000
-40.6%
64,100
-37.9%
0.01%
-50.0%
Q1 2018$1,698,000
+138.5%
103,200
+180.5%
0.01%
+233.3%
Q3 2017$712,000
+401.4%
36,785
+204.0%
0.00%
+200.0%
Q2 2017$142,000
-84.7%
12,100
-85.7%
0.00%
-85.7%
Q1 2017$928,000
+174.6%
84,700
+81.8%
0.01%
+250.0%
Q4 2016$338,000
+160.0%
46,600
+133.0%
0.00%
+100.0%
Q3 2016$130,000
+6400.0%
20,000
+4900.0%
0.00%
Q2 2016$2,0000.0%400
-20.0%
0.00%
Q4 2015$2,000
-75.0%
500
-75.0%
0.00%
Q3 2015$8,0002,0000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders